The Molecular Basis of Androgen Insensitivity
Authors:
- Olaf HiortOHOlaf Hiort
- 1 July 2000
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 54 (5-6) , 327-333
Abstract
Androgen action is mediated in the peripheral target cell via the androgen receptor (AR). The AR is a nuclear transcription factor, combining a DNA-binding and a hormone-binding domain with a large transactivation unit. Androgen insensitivity syndrome (AIS) as the clinical entity of defective androgen action with variable phenotypes in 46,XY patients is caused by mutations of the X-chromosomal AR gene. Most variations in the AR gene are point mutations inhibiting either hormone or DNA binding. However, even within the same family, the phenotype for a given mutation can vary widely. Only few influential factors have been identified for the phenotypic diversity. For mutations affecting hormone binding, ligand concentration variability during fetal life may be an important influence on residual androgen action. A second factor is the occurrence of postzygotic de novo mutations, which are present at a high rate in single-case families. These somatic mutations lead to expression of both mutant and wild-type AR in a single patient and thus allow androgen action despite a deleterious mutation of the AR gene. Third, residual androgen response may be mediated by additional transcripts of the AR gene which are present in several cell types and can be affected in a different pattern by splice-site mutations. Whether differential expression of AR-interacting proteins has an influence on phenotype has not yet been proven. Moreover, little is known about the regulation of AR-dependent genes. Their identification is needed to understand post-AR action and, hence, androgenic control of sexual differentiation and maturation.Keywords
This publication has 10 references indexed in Scilit:
- Domain Requirements of DnaJ-like (Hsp40) Molecular Chaperones in the Activation of a Steroid Hormone ReceptorJournal of Biological Chemistry, 1999
- Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor geneThe Lancet, 1999
- The Linkage of Kennedy's Neuron Disease to ARA24, the First Identified Androgen Receptor Polyglutamine Region-associated CoactivatorJournal of Biological Chemistry, 1999
- Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG RepeatThe American Journal of Human Genetics, 1999
- Androgen Receptor-Mediated Hypersensitivity to Androgens in Women with Nonhyperandrogenic Hirsutism: Skewing of X-Chromosome InactivationThe Journal of Clinical Endocrinology & Metabolism, 1999
- The CAG repeat within the androgen receptor gene and its relationship to prostate cancerProceedings of the National Academy of Sciences, 1997
- Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor geneEuropean Journal of Pediatrics, 1996
- Differential display RT PCR of total RNA from human foreskin fibroblasts for investigation of androgen-dependent gene expressionAmerican Journal of Medical Genetics, 1996
- Androgen receptor defects: historical, clinical, and molecular perspectives [published erratum appears in Endocr Rev 1995 Aug;16(4):546]Endocrine Reviews, 1995
- Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophyNature, 1991